FindTrial
Sign In

Effects of anaesthetic agents on natural killer cells during ovarian surgery.

Effects of anaesthetic agents on natural killer cells and biomarker release during stage 3 Epithelial ovarian cancer surgery. A prospective pharmacodynamic cohort study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/034915
Enrollment
55
Registered
2021-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C569- Malignant neoplasm of unspecifiedovary

Interventions

None listed

Sponsors

S Seetheraman
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1&2 Stage 3 Epithelial ovarian cancer

Exclusion criteria

Exclusion criteria: Age >70 ASA 3&4 Secondary Cancer

Design outcomes

Primary

MeasureTime frame
Quantify the dynamic changes in CD56 CD3 and HIF 1alpha Timepoint: Before induction of anesthesia, After induction of anesthesia 2 hrs after surgical incision—

Secondary

MeasureTime frame
Disease free survivalTimepoint: 3 years from the day of surgery—

Countries

India

Contacts

Public ContactDr Punitha C

Cancer Institute(WIA)

punithaari@gmail.com9944733331

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026